Home
Matthew T. Wiley, Chief Commercial Officer: Definium Therapeutics DFTX Planned sale · Filed 06/25
Trade details
- Type
- Planned sale notice
- Planned sale date
- 26/06/25
- Filed
- 26/06/25
$120.8K to be sold
Definium Therapeutics trades, last 26 weeks
What else happened in Definium Therapeutics around then
Filed or reported within 30 days of the trade day · 05/26~07/25Matthew T. Wiley's recent trades
- Matthew T. Wiley
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$113.3K
3,097 sh
$113.3K
Filed 09/29
Traded 09/25
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$113.8K
3,097 sh
$113.8K
Filed 09/25
Traded 09/25
- Matthew T. Wiley
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$129.1K
2,867 sh
$129.1K
Filed 06/26
Traded 06/25
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$3,450
6,272 sh
$3,450
Filed 24/10/03
Traded 24/10/03
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$148
215 sh
$148
Filed 24/09/17
Traded 24/09/16
